TDOC RSI Chart
Last 7 days
-4.8%
Last 30 days
-16.5%
Last 90 days
-40.1%
Trailing 12 Months
-51.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 2.6B | 0 | 0 | 0 |
2023 | 2.5B | 2.5B | 2.6B | 2.6B |
2022 | 2.1B | 2.2B | 2.3B | 2.4B |
2021 | 1.4B | 1.6B | 1.9B | 2.0B |
2020 | 605.5M | 716.3M | 867.1M | 1.1B |
2019 | 456.8M | 492.6M | 519.6M | 553.3M |
2018 | 280.0M | 330.0M | 372.3M | 417.9M |
2017 | 139.2M | 157.3M | 193.5M | 233.3M |
2016 | 87.8M | 96.0M | 108.4M | 123.2M |
2015 | 50.6M | 58.6M | 67.7M | 77.4M |
2014 | 0 | 27.8M | 35.7M | 43.5M |
2013 | 0 | 0 | 0 | 19.9M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 02, 2024 | raman-tangella vidya | sold | -46,831 | 12.688 | -3,691 | chief medical officer |
May 02, 2024 | waters michael willem | sold | -73,501 | 12.688 | -5,793 | chief operating officer |
May 02, 2024 | kornwasser laizer | sold | -132,095 | 12.688 | -10,411 | president, enterprise growth |
May 01, 2024 | raman-tangella vidya | acquired | - | - | 10,244 | chief medical officer |
May 01, 2024 | kornwasser laizer | acquired | - | - | 20,198 | president, enterprise growth |
May 01, 2024 | waters michael willem | acquired | - | - | 11,319 | chief operating officer |
Apr 17, 2024 | trencher daniel | sold | -13,210 | 13.21 | -1,000 | chief strategy officer |
Apr 02, 2024 | nanis nikolaos p. | sold | -6,598 | 14.314 | -461 | chief technology officer |
Apr 01, 2024 | nanis nikolaos p. | acquired | - | - | 1,232 | chief technology officer |
Mar 25, 2024 | geshuri arnnon | sold | -112,950 | 15.06 | -7,500 | chief people officer |
Which funds bought or sold TDOC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 07, 2024 | Cornerstone Planning Group LLC | unchanged | - | -771 | 1,125 | -% |
May 07, 2024 | Strengthening Families & Communities, LLC | reduced | -67.37 | -25,553 | 8,000 | -% |
May 07, 2024 | Quantum Private Wealth, LLC | reduced | -1.72 | -279,370 | 617,908 | 0.23% |
May 07, 2024 | O'Dell Group, LLC | sold off | -100 | -1,940 | - | -% |
May 07, 2024 | MONTAG A & ASSOCIATES INC | unchanged | - | -37,113 | 86,886 | -% |
May 07, 2024 | AllSquare Wealth Management LLC | sold off | -100 | -5,107 | - | -% |
May 07, 2024 | M&T Bank Corp | sold off | -100 | -240,733 | - | -% |
May 07, 2024 | OPPENHEIMER ASSET MANAGEMENT INC. | reduced | -49.32 | -87,280 | 94,360 | -% |
May 07, 2024 | Arizona State Retirement System | reduced | -1.33 | -306,679 | 687,035 | -% |
May 07, 2024 | RIVER GLOBAL INVESTORS LLP | sold off | -100 | -158,580 | - | -% |
Unveiling Teladoc Health Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Teladoc Health Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 463.9B | 371.6B | 20.73 | 1.25 | ||||
CI | 98.7B | 206.0B | 25.6 | 0.48 | ||||
HCA | 81.0B | 66.7B | 14.81 | 1.21 | ||||
CVS | 68.9B | 360.9B | 9.41 | 0.19 | ||||
CNC | 40.5B | 155.5B | 14.8 | 0.26 | ||||
DVA | 11.9B | 12.3B | 14.61 | 0.97 | ||||
UHS | 11.4B | 14.7B | 13.95 | 0.78 | ||||
MID-CAP | ||||||||
CHE | 8.7B | 2.3B | 30.56 | 3.78 | ||||
ACHC | 6.1B | 3.0B | -542.41 | 2.05 | ||||
AMN | 2.3B | 3.8B | 10.84 | 0.6 | ||||
AMEH | 2.1B | 1.4B | 34.78 | 1.52 | ||||
SMALL-CAP | ||||||||
ADUS | 1.8B | 1.1B | 26.7 | 1.61 | ||||
BKD | 1.4B | 3.0B | -7.76 | 0.44 | ||||
BEAT | 55.0M | - | -3.76 | - | ||||
AMS | 19.3M | 21.3M | 36.22 | 0.91 |
Teladoc Health Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -2.2% | 646,131,000 | 660,527,000 | 660,238,000 | 652,406,000 | 629,244,000 | 637,709,000 | 611,402,000 | 592,379,000 | 565,350,000 | 554,235,000 | 521,658,000 | 503,139,000 | 453,675,000 | 383,321,000 | 288,812,000 | 241,030,000 | 180,799,000 | 156,489,000 | 137,969,000 | 130,276,000 | 128,573,000 |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 83,896,000 |
Costs and Expenses | 5.4% | 733,253,000 | 695,608,000 | 724,963,000 | 724,051,000 | 706,346,000 | 4,453,262,000 | 683,132,000 | 3,688,931,000 | 7,234,729,000 | 595,664,000 | 582,234,000 | 582,087,000 | 538,353,000 | 841,827,000 | 308,537,000 | 248,209,000 | 201,810,000 | 172,077,000 | 157,913,000 | 152,299,000 | 151,460,000 |
S&GA Expenses | 1.7% | 54,364,000 | 53,451,000 | 52,309,000 | 53,530,000 | 54,490,000 | 56,279,000 | 54,634,000 | 57,930,000 | 58,329,000 | 59,330,000 | 62,602,000 | 63,856,000 | 64,793,000 | 93,942,000 | 23,483,000 | 18,687,000 | 17,940,000 | 16,751,000 | 16,120,000 | 15,832,000 | 16,212,000 |
R&D Expenses | -9.5% | 81,388,000 | 89,938,000 | 84,289,000 | 87,309,000 | 86,985,000 | 82,931,000 | 84,590,000 | 78,696,000 | 87,412,000 | 72,867,000 | 80,250,000 | 80,759,000 | 78,008,000 | 92,697,000 | 29,958,000 | 23,029,000 | 19,257,000 | 16,246,000 | 15,746,000 | 16,665,000 | 15,987,000 |
EBITDA Margin | -3.7% | -0.08 | -0.08 | -1.42 | -1.47 | -2.74 | -5.56 | -4.10 | -4.29 | -3.09 | -0.05 | -0.37 | -0.42 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 2.0% | 5,649,000 | 5,538,000 | 5,646,000 | 5,835,000 | 5,263,000 | 10,151,000 | 6,149,000 | 5,562,000 | -5,480,000 | 142,634,000 | -18,895,000 | -20,473,000 | -22,125,000 | -21,100,500 | -16,970,000 | -13,262,000 | -8,618,000 | -7,581,000 | -7,700,000 | -7,211,000 | -6,521,000 |
Income Taxes | -23.5% | 2,690,000 | 3,515,000 | -2,484,000 | -952,000 | 681,000 | -1,841,000 | -1,171,000 | -1,188,000 | 388,000 | -49,734,500 | 3,643,000 | 3,200,000 | 87,000,000 | -85,457,500 | -2,300,000 | -2,399,000 | -700,000 | -4,125,000 | -7,300,000 | 100,000 | 742,000 |
Earnings Before Taxes | -212.1% | -79,199,000 | -25,375,000 | -59,557,000 | -66,129,000 | -68,547,000 | -3,811,912,000 | -74,647,000 | -3,102,649,000 | -6,674,135,000 | -60,726,000 | -80,697,000 | -130,623,000 | -112,610,000 | -479,424,000 | -38,174,000 | -28,081,000 | -30,314,000 | -23,169,000 | -27,644,000 | -29,234,000 | -29,408,000 |
EBT Margin | -4.2% | -0.09 | -0.08 | -1.55 | -1.59 | -2.86 | -5.68 | -4.27 | -4.44 | -3.24 | -0.19 | -0.43 | -0.47 | - | - | - | - | - | - | - | - | - |
Net Income | -183.5% | -81,889,000 | -28,890,000 | -57,073,000 | -65,177,000 | -69,228,000 | -3,810,071,000 | -73,476,000 | -3,101,461,000 | -6,674,523,000 | -10,985,000 | -84,340,000 | -133,819,000 | -199,649,000 | -393,967,000 | -35,884,000 | -25,682,000 | -29,603,000 | -19,044,000 | -20,346,000 | -29,324,000 | -30,150,000 |
Net Income Margin | -5.1% | -0.09 | -0.08 | -1.55 | -1.59 | -2.86 | -5.68 | -4.24 | -4.42 | -3.22 | -0.21 | -0.44 | -0.47 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -94.0% | 7,771,000 | 128,678,000 | 99,808,000 | 99,278,000 | 10,793,000 | 59,354,000 | 59,191,000 | 89,927,000 | -35,660,000 | 80,285,000 | 75,385,000 | 49,927,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -1.6% | 4,321 | 4,392 | 4,328 | 4,316 | 4,309 | 4,345 | 8,104 | 8,103 | 11,092 | 17,735 | 17,653 | 17,611 | 17,582 | 17,755 | 3,449 | 2,419 | 1,603 | 1,603 | 1,568 | 1,565 | 1,552 |
Current Assets | -0.2% | 1,486 | 1,489 | 1,387 | 1,321 | 1,287 | 1,315 | 1,288 | 1,257 | 1,208 | 1,225 | 1,157 | 1,105 | 1,032 | 1,060 | 1,310 | 1,403 | 596 | 588 | 558 | 533 | 541 |
Cash Equivalents | -2.3% | 1,098 | 1,124 | 1,031 | 959 | 889 | 918 | 900 | 881 | 836 | 893 | 824 | 784 | 720 | 733 | 1,187 | 1,309 | 508 | 514 | 475 | 440 | 434 |
Inventory | 9.3% | 32.00 | 30.00 | 36.00 | 34.00 | 46.00 | 56.00 | 59.00 | 60.00 | 71.00 | 73.00 | 57.00 | 57.00 | 58.00 | 56.00 | 12.00 | - | - | - | - | - | - |
Net PPE | -7.7% | 30.00 | 32.00 | 33.00 | 30.00 | 30.00 | 30.00 | 27.00 | 27.00 | 28.00 | 27.00 | 27.00 | 28.00 | 28.00 | 29.00 | 20.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Goodwill | 0% | 1,073 | 1,073 | 1,073 | 1,073 | 1,073 | 1,073 | 4,846 | 4,858 | 7,900 | 14,504 | 14,470 | 14,455 | 14,452 | 14,581 | 1,691 | 900 | 734 | 746 | 738 | 748 | 734 |
Current Liabilities | -7.6% | 389 | 421 | 403 | 383 | 381 | 400 | 411 | 371 | 307 | 331 | 302 | 276 | 260 | 333 | 201 | 124 | 97.00 | 90.00 | 85.00 | 70.00 | 72.00 |
Long Term Debt | 0.1% | 1,540 | 1,539 | 1,538 | 1,537 | 1,536 | 1,535 | 1,534 | 1,534 | 1,533 | 1,226 | 1,211 | 1,201 | 1,353 | 1,380 | 953 | 948 | 447 | 440 | 434 | 427 | 421 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 43.00 | - | - | - | - | - | - | - |
LT Debt, Non Current | 0.1% | 1,540 | 1,539 | 1,538 | 1,537 | 1,536 | 1,535 | 1,534 | 1,534 | 1,533 | 1,226 | 1,211 | 1,201 | 1,353 | 1,380 | 953 | 948 | 447 | 440 | 434 | 427 | 421 |
Shareholder's Equity | -1.6% | 2,289 | 2,326 | 2,294 | 2,295 | 2,291 | 2,308 | 6,053 | 6,085 | 9,143 | 16,046 | 15,988 | 16,001 | 15,829 | 15,884 | 2,231 | 1,295 | 1,000 | 1,014 | 994 | 1,003 | 1,002 |
Retained Earnings | -0.5% | -15,310 | -15,228 | -15,199 | -15,142 | -15,077 | -15,008 | -11,198 | -11,124 | -8,023 | -1,421 | -1,410 | -1,326 | -1,192 | -992 | -598 | -562 | -537 | -507 | -488 | -468 | -438 |
Additional Paid-In Capital | 0.3% | 17,638 | 17,592 | 17,535 | 17,476 | 17,410 | 17,359 | 17,300 | 17,239 | 17,177 | 17,473 | 17,399 | 17,315 | 17,017 | 16,858 | 2,835 | 1,880 | 1,572 | 1,539 | 1,510 | 1,483 | 1,457 |
Shares Outstanding | 1.6% | 169 | 167 | 166 | 165 | 163 | 163 | 162 | 161 | 161 | 157 | 156 | 154 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 4,145 | - | - | - | 5,334 | - | - | - | 26,317 | - | - | - | 14,937 | - | - | - | 4,607 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -93.1% | 8,920 | 130,082 | 105,601 | 101,182 | 13,156 | 65,549 | 63,021 | 92,469 | -31,747 | 83,208 | 76,591 | 52,217 | -18,026 | -114,936 | 32,195 | 35,550 | -6,320 | 18,122 | 13,490 | 6,149 | -7,892 |
Share Based Compensation | -9.6% | 42,325 | 46,823 | 52,964 | 55,725 | 46,038 | 50,754 | 55,662 | 51,000 | 60,436 | 61,615 | 71,701 | 82,970 | 86,300 | 414,380 | 20,908 | 21,928 | 18,315 | 18,457 | 17,354 | 17,368 | 13,523 |
Cashflow From Investing | 2.7% | -35,512 | -36,506 | -37,647 | -36,570 | -45,624 | -53,891 | -41,448 | -44,837 | -27,567 | -20,075 | -34,708 | -2,168 | -16,030 | -413,925 | -155,460 | -9,662 | -11,928 | 9,547 | 13,194 | -5,064 | 7,336 |
Cashflow From Financing | 198.6% | 1,751 | -1,775 | 5,068 | 4,208 | 3,353 | 4,381 | 634 | -1,334 | 2,816 | 6,625 | 784 | 11,363 | 22,175 | 70,436 | 422 | 773,225 | 15,053 | 10,041 | 9,153 | 5,198 | 10,702 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 646,131 | $ 629,244 |
Expenses: | ||
Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) | 194,538 | 190,107 |
Operating expenses: | ||
Advertising and marketing | 183,329 | 176,790 |
Sales | 54,364 | 54,490 |
Technology and development | 81,388 | 86,985 |
General and administrative | 111,697 | 114,145 |
Acquisition, integration, and transformation costs | 373 | 5,944 |
Restructuring costs | 9,673 | 8,102 |
Amortization of intangible assets | 95,057 | 66,860 |
Depreciation of property and equipment | 2,834 | 2,923 |
Total expenses | 733,253 | 706,346 |
Loss from operations | (87,122) | (77,102) |
Interest income | (13,942) | (8,911) |
Interest expense | 5,649 | 5,263 |
Other expense (income), net | 370 | (4,907) |
Loss before provision for income taxes | (79,199) | (68,547) |
Provision for income taxes | 2,690 | 681 |
Net loss | (81,889) | (69,228) |
Other comprehensive loss, net of tax: | ||
Currency translation adjustment | (1,639) | 1,779 |
Comprehensive loss | $ (83,528) | $ (67,449) |
Net loss per share, basic (in dollars per share) | $ (0.49) | $ (0.42) |
Net loss per share, diluted (in dollars per share) | $ (0.49) | $ (0.42) |
Weighted-average shares used to compute basic net loss per share (in shares) | 167,730,746 | 162,922,691 |
Weighted-average shares used to compute diluted net loss per share (in shares) | 167,730,746 | 162,922,691 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,097,935 | $ 1,123,675 |
Accounts receivable, net of allowance for doubtful accounts of $3,530 and $4,240 at March 31, 2024 and December 31, 2023, respectively | 214,293 | 217,423 |
Inventories | 32,268 | 29,513 |
Prepaid expenses and other current assets | 141,769 | 118,437 |
Total current assets | 1,486,265 | 1,489,048 |
Property and equipment, net | 29,550 | 32,032 |
Goodwill | 1,073,190 | 1,073,190 |
Intangible assets, net | 1,614,238 | 1,677,781 |
Operating lease - right-of-use assets | 37,506 | 40,060 |
Other assets | 80,007 | 80,258 |
Total assets | 4,320,756 | 4,392,369 |
Current liabilities: | ||
Accounts payable | 37,674 | 43,637 |
Accrued expenses and other current liabilities | 199,418 | 178,634 |
Accrued compensation | 50,523 | 102,686 |
Deferred revenue-current | 101,229 | 95,659 |
Total current liabilities | 388,844 | 420,616 |
Other liabilities | 1,023 | 1,080 |
Operating lease liabilities, net of current portion | 39,971 | 42,837 |
Deferred revenue, net of current portion | 15,002 | 13,623 |
Deferred taxes, net | 47,472 | 49,452 |
Convertible senior notes, net | 1,539,546 | 1,538,688 |
Commitments and contingencies (Note 14) | ||
Stockholders’ equity: | ||
Common stock, $0.001 par value; 300,000,000 shares authorized; 169,314,029 shares and 166,658,253 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 169 | 167 |
Additional paid-in capital | 17,637,902 | 17,591,551 |
Accumulated deficit | (15,310,544) | (15,228,655) |
Accumulated other comprehensive loss | (38,629) | (36,990) |
Total stockholders’ equity | 2,288,898 | 2,326,073 |
Total liabilities and stockholders’ equity | $ 4,320,756 | $ 4,392,369 |